25P Research-based HER2DX in patients with early-stage HER2-positive (HER2+) breast cancer treated in the N9831 phase III clinical trial
Title:
25P Research-based HER2DX in patients with early-stage HER2-positive (HER2+) breast cancer treated in the N9831 phase III clinical trial
Author:
Brasó-Maristany, F. Martinez Saez, O. Pare Brunet, L. Marín-Aguilera, M. Conte, P.F. Jares, P. Guarneri, V. Pascual, T. Puig-Butille, J.A. Vivancos, A. Parker, J. Villagrasa Gonzalez, P. Tolaney, S.M. Carey, L.A. Perou, C.M. Prat, A.